Figure 2

(A) Progression-free survival (PFS) among 30 cases of primary (not recurrent) non-germinomatous GCTs was compared between cases with and without 3p25.3 gain. Those with 3p25.3 gain showed significantly shorter PFS than those without (p = 0.047). (B) Comparison of overall survival (OS) among 30 cases of primary (not recurrent) non-germinomatous GCTs between cases with and without 3p25.3 gain. No significant difference was found, although a trend was seen toward shorter OS in cases with 3p25.3 gain.